Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-01-06 23:38 Tx date 2021-01-05 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,600
-30,000 vol $0.82 each |
1,634,987 | |
Filed 2021-01-06 23:37 Tx date 2021-01-05 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,581
-30,000 vol $0.85 each |
1,664,987 | |
Filed 2021-01-06 23:37 Tx date 2021-01-05 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80,000
-100,000 vol $0.80 each |
1,694,987 | |
Filed 2021-01-06 23:36 Tx date 2021-01-04 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,100
-10,000 vol $0.91 each |
1,794,987 | |
Filed 2021-01-06 23:35 Tx date 2021-01-04 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,200
-10,000 vol $0.92 each |
1,804,987 | |
Filed 2020-09-04 10:27 Tx date 2020-09-04 |
$
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
Filed 2020-09-04 10:27 Tx date 2020-09-04 |
$
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,814,987 |